Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome

This publication has 27 references indexed in Scilit:

• Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome
  Nature Neuroscience, 2007
• The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome
  The Journal of Physiology, 2007
• Donepezil for dementia due to Alzheimer's disease
  Cochrane Database of Systematic Reviews, 2006
• Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome
  Journal of Neuroscience, 2004
• Donepezil effects on language in children with Down syndrome: Results of the first 22‐week pilot clinical trial
  American Journal of Medical Genetics Part A, 2004
• Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population
  International Journal of Geriatric Psychiatry, 2004
• The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse
  Behavioural Brain Research, 2004
• Donepezil for the treatment of language deficits in adults with Down syndrome: A preliminary 24‐week open trial
  American Journal of Medical Genetics Part A, 2002
• Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome
  Behavioural Brain Research, 2002
• A behavioral assessment of Ts65Dn mice: a putative Down syndrome model
  Neuroscience Letters, 1995